Author: Ueda, Yuki; Kenzaka, Tsuneaki; Noda, Ayako; Yamamoto, Yu; Matsumura, Masami
Title: Adult-onset Kawasaki disease (mucocutaneous lymph node syndrome) and concurrent Coxsackievirus A4 infection: a case report Document date: 2015_9_29
ID: 019lkt6k_11
Snippet: KD most commonly develops in infants. The annual incidence is 67 cases per 100,000 children in Japan and 5.6 cases per 100,000 children in the USA. Children under 5 years of age constitute 88.5% of reported cases. 2,3 KD occurs predominantly in children while rarely in adolescents and adults. 4 The oldest reported case was that of a 68-year-old Caucasian man from France in 2005. 9 The diagnostic criteria for KD as defined by the Centers for Disea.....
Document: KD most commonly develops in infants. The annual incidence is 67 cases per 100,000 children in Japan and 5.6 cases per 100,000 children in the USA. Children under 5 years of age constitute 88.5% of reported cases. 2,3 KD occurs predominantly in children while rarely in adolescents and adults. 4 The oldest reported case was that of a 68-year-old Caucasian man from France in 2005. 9 The diagnostic criteria for KD as defined by the Centers for Disease Control and Prevention include unexplained fever lasting 5 days or more and at least four out of the five following criteria: 1) polymorphic exanthema; 2) changes in the peripheral extremities, that is, erythema Notes: on the day of admission to our hospital, he was treated with 30 mg/kg/day of oral aspirin. on day 4, the dose of aspirin was reduced to 5 mg/kg/day because of defervescence. after day 6 in our hospital, the myalgia, congested conjunctivae, erythema, and desquamations gradually resolved. By day 13, the erythema and desquamation were completely resolved. However, the treatment was switched from aspirin to 200 mg/day of cilostazol because of liver dysfunction as an adverse effect of aspirin. Abbreviations: WBC, White blood cell count; plt, platelet; aLt, alanine aminotransferase.
Search related documents:
Co phrase search for related documents- adult adolescent and alanine aminotransferase: 1, 2
- adverse effect and alanine aminotransferase: 1
- adverse effect and aspirin adverse effect: 1, 2
- adverse effect and aspirin adverse effect liver dysfunction: 1, 2
- adverse effect and aspirin dose: 1, 2
- adverse effect and cilostazol day: 1, 2
- adverse effect and desquamation erythema: 1
- alanine aminotransferase and aspirin adverse effect: 1
- alanine aminotransferase and aspirin adverse effect liver dysfunction: 1
- alanine aminotransferase and aspirin dose: 1, 2
- alanine aminotransferase and blood cell count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- alanine aminotransferase and cell count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- alanine aminotransferase and cilostazol day: 1
- alanine aminotransferase and desquamation erythema: 1
- annual incidence and aspirin dose: 1
- annual incidence and blood cell count: 1
- annual incidence and cell count: 1
- aspirin adverse effect and cilostazol day: 1, 2
- aspirin adverse effect and desquamation erythema: 1
Co phrase search for related documents, hyperlinks ordered by date